COMMUNIQUÉS West-GlobeNewswire

BioSig Appoints John Kowalski to Lead Commercialization of PURE EP
05/02/2019
Electrophysiology Industry Veteran to Lead Sales Strategy for the Company’s Novel Cardiac Signal Acquisition and Processing Technology Santa Monica, CA, Feb. 05, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. ( [...]
Arch Therapeutics to Provide Corporate Update at the 2019 BIO CEO & Investor Conference
05/02/2019
FRAMINGHAM, Mass., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a [...]
MediPharm Labs Aligns Leadership and Organizational Structure For Future Prosperity of Company
05/02/2019
TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (the “Company” or “MediPharm Labs”) the leader in specialized, research-driven cannabis extraction, is pleased to announce the [...]
Intensity Therapeutics to Participate in Panel at 2019 BIO CEO & Investor Conference
05/02/2019
WESTPORT, Conn., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc. , a clinical-stage biotechnology company developing proprietary technology and products to kill tumors and increase immune cell recognition [...]
Moleculin Announces the FDA has Granted Orphan Drug Designation for its Brain Tumor Drug
05/02/2019
HOUSTON, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]
Recent American Society of Breast Surgeons (ASBrS) Guidelines are Favorable to Next Generation Cryoablation Developer, IceCure Medical
05/02/2019
Plans to Increase Presence at Global Interventional Oncology (IO) Medical Conferences CAESAREA, Israel, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Following the American Society of Breast Surgeons (ASBrS) Guideline, which were [...]
OpGen Completes Clinical Trials for its Initial FDA 510(k) Submission
05/02/2019
GAITHERSBURG, Md., Feb. 05, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today that it has completed the clinical trials needed to support its 510(k) submission for the detection of antimicrobial [...]
Cyclacel Pharmaceuticals to Present at the 2019 BIO CEO & Investor Conference
05/02/2019
BERKELEY HEIGHTS, N.J., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on [...]
Kamada to Announce Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results and Host Conference Call on February 12
05/02/2019
REHOVOT, Israel, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today announced that it will release financial results for the fourth quarter and [...]
Emerald Health Therapeutics Secures Proprietary Extraction Technology and Extraction Capabilities in Agreement with Indena
05/02/2019
Emerald receives certain exclusive rights to established Phytosome ® technology to enhance absorption and bioavailability of cannabinoid products Leading global extraction researcher and manufacturer to provide license [...]
Microbix Provides Quality Assessment Products Update
05/02/2019
New Customers, More Products, and Expanding Capacity TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, provides an update on [...]
BioCryst to Present ZENITH-1 Results at American Academy of Allergy, Asthma & Immunology Annual Meeting
05/02/2019
RESEARCH TRIANGLE PARK, N.C., Feb. 05, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present an abstract including results from the ZENITH-1 study at the [...]
Harrow Health Announces $11 Million Series A Financing for Melt Pharmaceuticals Subsidiary
05/02/2019
Investment will enable Melt to fund the development of its patented, non-opioid sublingual sedation and analgesia drug candidate, MELT-100 SAN DIEGO and BOSTON, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Melt Pharmaceuticals, [...]
Protalix BioTherapeutics Presents Preliminary Data from the BRIGHT Study of pegunigalsidase alfa for the Treatment of Fabry Disease at the 15th Annual WORLDSymposium™ 2019
05/02/2019
~ Pharmacokinetic data from patients treated in the study show that infusion of pegunigalsidase alfa every 4 weeks results in the presence of continuous active enzyme throughout the entire infusion interval~ ~Continuous [...]
Revive Announces Closing of the First Tranche of Its Non-Brokered Private Placement for Total Gross Proceeds of Over $1 Million
05/02/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics [...]
Tetra Bio-Pharma Redefines Quality Standards for Pharmaceutical Grade Cannabis-Derived Products
05/02/2019
Patient safety is primary imperative ORLEANS, Ontario, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX-V: TBP) (OTCQB: TBPMF), today announced that it has temporarily [...]
CorVel Announces Revenues and Earnings
05/02/2019
IRVINE, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended December 31, 2018. Revenues for the quarter ended December 31, 2018 were $146 million, an [...]
Coloplast delivers solid start to the year with 8% organic growth
05/02/2019
Coloplast delivered 8% organic growth and EBIT increased by 8% to DKK 1,297m, corresponding to an EBIT margin of 30%, in the first quarter of the 2018/19 financial year. The company maintains its financial guidance for [...]
Press release: Terveystalo dental clinic network expands - Länsi-Vantaan Hammaslääkärit Oy to become a part of Terveystalo
05/02/2019
Terveystalo has signed an agreement to acquire Länsi-Vantaan Hammaslääkärit Oy, a private clinic that offers oral health services in Vantaa. The company's employees will be transferred to Terveystalo as old employees [...]

Pages